Man Dies After Inhaler Cost Jumps $500, According to Family’s Lawsuit

Wisconsin Man Dies After Inhaler Cost Jumps $500

A Wisconsin family has filed a lawsuit against pharmaceutical companies after their son, 22-year-old Cole Schmidtknecht, died following an alleged price increase of his asthma inhaler. Schmidtknecht, who suffered from chronic asthma, had long relied on the Advair Diskus inhaler, which he had previously obtained for approximately $66. However, the family claims that the price of the inhaler skyrocketed by $500, making it unaffordable for him.

According to the lawsuit, Schmidtknecht was unable to purchase the inhaler due to its prohibitive cost. Without it, he experienced a severe asthma attack, leading to his untimely death. The family asserts that the dramatic price increase directly contributed to his passing and highlights the broader issue of the high cost of life-saving medications in the United States.

The lawsuit names the manufacturers of Advair Diskus as responsible for what the family describes as an unjustified and exploitative price hike. They argue that pharmaceutical companies have a duty to ensure that essential medications remain accessible to those who rely on them for survival.

The rising cost of prescription medications, particularly for chronic conditions like asthma, has been a contentious issue in recent years. Advocates for affordable healthcare have repeatedly criticized pharmaceutical companies for pricing medications out of reach for many patients, sometimes forcing them to go without necessary treatment.

Schmidtknecht’s family hopes that their lawsuit will bring attention to the financial barriers that prevent individuals from accessing critical medical treatments and inspire legislative action to prevent similar tragedies.

As the legal case unfolds, it raises important questions about pharmaceutical pricing practices, patient accessibility, and the ethical responsibilities of drug manufacturers. For many, the lawsuit serves as a stark reminder of the dire consequences of an unchecked pharmaceutical market where affordability can be the difference between life and death.

Share this post :

Comments on this Article:

😊 😂 😍 👍 🎉 💯 😢 😎 ❤️

No comments available for this post.